Clinical Pharmacology Services
Dedicated to adaptive early phase clinical trials and drug development, Quotient Sciences can help accelerate your molecule from first-in-human (FIH) to proof of concept (POC). Our main goal is to deliver the insights our clients need for confidently outlining and delivering their clinical pharmacology programme. Our fully integrated approach ensures seamless execution and high-quality results—delivered safely and rapidly. Our experience spans more than 30 years with more than 1,300 Phase I studies delivered at our clinical units in Miami and Nottingham.
We deliver comprehensive clinical pharmacology services and a full suite of healthy volunteer studies, delivered with the highest-quality service and speed. Study types include first-in-human clinical studies (FIH), single and multiple ascending dose (SAD/MAD), bioequivalence (BE), drug-drug interactions (DDI), and more.
Quotient Sciences clinical pharmacology services
- Over three decades of proven experience
- Our comprehensive clinical pharmacology services are delivered by expert teams, and include data management, analysis and interpretation, as well as clinical study report generation.
- Industry-leading clinical project management
- Tailored, high-quality results are delivered under a single contract and project manager. Over 90% of our customers say they plan to work with us again in the future.
- High-quality regulatory submissions
- Our deep regulatory understanding and strong relationships with regulators result in high-quality submissions and fast IRB and REC/MHRA approvals.
- Rapid volunteer recruitment
- With a database of 31,500 active volunteers and a volunteer-centric approach, we’re proud of our achievements: 99% of our studies start on time, 98% with full enrollment, and 99% retention rate.
- Seamless delivery of complex protocols
- Our scientific and medical teams provide trusted advice on your optimal study design, leveraging extensive experience in complex protocols, including multi-part, flexible, and umbrella designs.
